MMP9 and Stroke: A combination of rheumatoid factor, matrix metalloproteinase-9 and total Hcy, improved the risk prediction of cognitive impairment in AIS patients with elevated blood pressure, demonstrating that Hcy is involved in several pathophysiological pathways that cause post-stroke cognitive impairment [19].